ZA200305725B - Novel carotenoid esters. - Google Patents
Novel carotenoid esters. Download PDFInfo
- Publication number
- ZA200305725B ZA200305725B ZA200305725A ZA200305725A ZA200305725B ZA 200305725 B ZA200305725 B ZA 200305725B ZA 200305725 A ZA200305725 A ZA 200305725A ZA 200305725 A ZA200305725 A ZA 200305725A ZA 200305725 B ZA200305725 B ZA 200305725B
- Authority
- ZA
- South Africa
- Prior art keywords
- carotenoids
- carotenoid
- lutein
- acid
- esters
- Prior art date
Links
- 235000021466 carotenoid Nutrition 0.000 title claims description 86
- -1 carotenoid esters Chemical class 0.000 title claims description 21
- 150000001747 carotenoids Chemical class 0.000 claims description 74
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 63
- 239000001656 lutein Substances 0.000 claims description 51
- 235000012680 lutein Nutrition 0.000 claims description 51
- 229960005375 lutein Drugs 0.000 claims description 51
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 51
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 51
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 49
- 239000001670 anatto Substances 0.000 claims description 36
- 235000012665 annatto Nutrition 0.000 claims description 36
- 150000002148 esters Chemical class 0.000 claims description 28
- 239000002253 acid Substances 0.000 claims description 26
- RAFGELQLHMBRHD-VFYVRILKSA-N Bixin Natural products COC(=O)C=CC(=C/C=C/C(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)/C)C RAFGELQLHMBRHD-VFYVRILKSA-N 0.000 claims description 22
- RAFGELQLHMBRHD-UHFFFAOYSA-N alpha-Fuc-(1-2)-beta-Gal-(1-3)-(beta-GlcNAc-(1-6))-GalNAc-ol Natural products COC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC(O)=O RAFGELQLHMBRHD-UHFFFAOYSA-N 0.000 claims description 22
- RAFGELQLHMBRHD-SLEZCNMESA-N bixin Chemical compound COC(=O)\C=C\C(\C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O RAFGELQLHMBRHD-SLEZCNMESA-N 0.000 claims description 21
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 claims description 14
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 claims description 14
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 claims description 14
- 150000001748 carotenols Chemical class 0.000 claims description 14
- 235000005471 carotenols Nutrition 0.000 claims description 14
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 12
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 12
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims description 12
- 235000010930 zeaxanthin Nutrition 0.000 claims description 12
- 239000001775 zeaxanthin Substances 0.000 claims description 12
- 229940043269 zeaxanthin Drugs 0.000 claims description 12
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 claims description 6
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 claims description 6
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 claims description 6
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 claims description 5
- 239000004212 Cryptoxanthin Substances 0.000 claims description 5
- 235000002360 beta-cryptoxanthin Nutrition 0.000 claims description 5
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 claims description 5
- 235000019244 cryptoxanthin Nutrition 0.000 claims description 5
- DVICWXUADSCSLL-DDEWRDOISA-N Alloxanthin/Tetradehydrozeaxanthin/(Cynthiaxanthin)/(Pectenoxanthin) Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1C#CC(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C#CC1=C(C)C[C@@H](O)CC1(C)C DVICWXUADSCSLL-DDEWRDOISA-N 0.000 claims description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 4
- DVICWXUADSCSLL-GUPSQEAKSA-N all-trans-Alloxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C#CC1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C#CC2=C(C)CC(O)CC2(C)C DVICWXUADSCSLL-GUPSQEAKSA-N 0.000 claims description 4
- UFRRRMXNFIGHPC-CPZJCIGYSA-N alloxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C#CC1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC#CC2=C(C)CC(O)CC2(C)C UFRRRMXNFIGHPC-CPZJCIGYSA-N 0.000 claims description 4
- NYWCITDWPAZNBU-DYISAODMSA-N Azafrin Chemical compound OC(=O)\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@@]1(O)C(C)(C)CCC[C@@]1(C)O NYWCITDWPAZNBU-DYISAODMSA-N 0.000 claims description 3
- NYWCITDWPAZNBU-SVBPBHIXSA-N Azafrin Natural products CC(=CC=CC=C(C)C=CC(=O)O)C=CC=C(C)C=C[C@]1(O)C(C)(C)CCC[C@]1(C)O NYWCITDWPAZNBU-SVBPBHIXSA-N 0.000 claims description 3
- 235000005473 carotenes Nutrition 0.000 claims description 3
- KOTBWDXNYNTNIY-YHEDCBSUSA-N hydroxycarotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C KOTBWDXNYNTNIY-YHEDCBSUSA-N 0.000 claims description 3
- IFTRFNLCKUZSNG-SFEKFZNLSA-N lycoxanthin Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CC\C=C(/C)CO IFTRFNLCKUZSNG-SFEKFZNLSA-N 0.000 claims description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000005886 esterification reaction Methods 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 230000032050 esterification Effects 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- 229920000728 polyester Polymers 0.000 description 6
- 239000000377 silicon dioxide Substances 0.000 description 6
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 5
- 239000004213 Violaxanthin Substances 0.000 description 5
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 5
- 238000004809 thin layer chromatography Methods 0.000 description 5
- 235000019245 violaxanthin Nutrition 0.000 description 5
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 150000005690 diesters Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 125000003158 alcohol group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000012658 paprika extract Nutrition 0.000 description 3
- 239000001688 paprika extract Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 2
- QXNWZXMBUKUYMD-ITUXNECMSA-N 4-keto-beta-carotene Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C QXNWZXMBUKUYMD-ITUXNECMSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 241000212749 Zesius chrysomallus Species 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 description 2
- 235000018889 capsanthin Nutrition 0.000 description 2
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000002635 lutein group Chemical group 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- BMQNSHDVIYZULR-FKKUPVFPSA-N (1r)-3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol Chemical compound CC=1C=CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C BMQNSHDVIYZULR-FKKUPVFPSA-N 0.000 description 1
- DMASLKHVQRHNES-GMKWGACXSA-N (1s)-3,5,5-trimethyl-4-[(1e,3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohex-3-en-1-ol Chemical compound C([C@@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DMASLKHVQRHNES-GMKWGACXSA-N 0.000 description 1
- GVOIABOMXKDDGU-XRODXAHISA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Chemical compound O=C([C@@]1(C)C(C[C@H](O)C1)(C)C)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C GVOIABOMXKDDGU-XRODXAHISA-N 0.000 description 1
- GVOIABOMXKDDGU-LOFNIBRQSA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)C1(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C GVOIABOMXKDDGU-LOFNIBRQSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-BAHRDPFUSA-N 15Z-phytoene Natural products CC(=CCCC(=CCCC(=CCCC(=CC=C/C=C(C)/CCC=C(/C)CCC=C(/C)CCC=C(C)C)C)C)C)C YVLPJIGOMTXXLP-BAHRDPFUSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OFNSUWBAQRCHAV-UHFFFAOYSA-N 9-cis-antheraxanthin Natural products O1C(CC(O)CC2(C)C)(C)C12C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CC(O)CC1(C)C OFNSUWBAQRCHAV-UHFFFAOYSA-N 0.000 description 1
- OFNSUWBAQRCHAV-MATJVGBESA-N Antheraxanthin Natural products O[C@H]1CC(C)(C)C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@]23C(C)(C)C[C@H](O)C[C@@]2(C)O3)\C)/C)\C)/C)=C(C)C1 OFNSUWBAQRCHAV-MATJVGBESA-N 0.000 description 1
- GVOIABOMXKDDGU-SUKXYCKUSA-N Capsorubin Natural products O=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C(=O)[C@@]1(C)C(C)(C)C[C@H](O)C1)\C)/C)\C)/C)[C@@]1(C)C(C)(C)C[C@H](O)C1 GVOIABOMXKDDGU-SUKXYCKUSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000004217 Citranaxanthin Substances 0.000 description 1
- SLQHGWZKKZPZEK-JKEZLOPUSA-N Citranaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)C)C=CC=C(/C)C=CC1=C(C)CCCC1(C)C SLQHGWZKKZPZEK-JKEZLOPUSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 102000010970 Connexin Human genes 0.000 description 1
- 108050001175 Connexin Proteins 0.000 description 1
- FMUTWECJHLYSSS-XUYZKQIISA-N Decaprenoxanthin Chemical compound CC1(C)[C@@H](C\C=C(CO)/C)CC=C(C)[C@H]1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)(C)[C@@H](C\C=C(/C)CO)CC=C1C FMUTWECJHLYSSS-XUYZKQIISA-N 0.000 description 1
- TVDRORHNCXFEQK-UHFFFAOYSA-N Decaprenoxanthin Natural products CC(=CCC1CCC(=C(C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C=CC2=C(C)CCC(CC(=C(CO)CO)C)C2(C)C)C)C)C1(C)C)C)C TVDRORHNCXFEQK-UHFFFAOYSA-N 0.000 description 1
- FMKGDHLSXFDSOU-BDPUVYQTSA-N Dienon-Astacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=CC1(C)C)O)C=CC=C(/C)C=CC2=C(C)C(=O)C(=CC2(C)C)O FMKGDHLSXFDSOU-BDPUVYQTSA-N 0.000 description 1
- GYZWNQLEQAGWGD-DKLMTRRASA-N Isozeaxanthin Chemical compound CC=1C(O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(O)CCC1(C)C GYZWNQLEQAGWGD-DKLMTRRASA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- IFTRFNLCKUZSNG-ZZAFTVETSA-N Lycoxanthin Natural products OC/C(=C\CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(\C)/C)\C)/C)\C)/C)\C)/C)/C IFTRFNLCKUZSNG-ZZAFTVETSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- UGJYMKZYSUMAKJ-YSMVHXPUSA-N Neurosporaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC=C(/C)C(=O)O UGJYMKZYSUMAKJ-YSMVHXPUSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000736851 Tagetes Species 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 235000012311 Tagetes erecta Nutrition 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- GYZWNQLEQAGWGD-LOFNIBRQSA-N all-trans-Isozeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(O)CCC1(C)C)C=CC=C(/C)C=CC2=C(C)C(O)CCC2(C)C GYZWNQLEQAGWGD-LOFNIBRQSA-N 0.000 description 1
- BMQNSHDVIYZULR-WZLJTJAWSA-N anhydrolutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C=CCC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C BMQNSHDVIYZULR-WZLJTJAWSA-N 0.000 description 1
- OFNSUWBAQRCHAV-OYQUVCAXSA-N antheraxanthin Chemical compound C(/[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C OFNSUWBAQRCHAV-OYQUVCAXSA-N 0.000 description 1
- 229930003362 apo carotenoid Natural products 0.000 description 1
- 150000002768 apo carotenoid derivatives Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- RASZIXQTZOARSV-QISQUURKSA-N astacene Chemical compound CC=1C(=O)C(=O)CC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(=O)CC1(C)C RASZIXQTZOARSV-QISQUURKSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000012682 canthaxanthin Nutrition 0.000 description 1
- 239000001659 canthaxanthin Substances 0.000 description 1
- 229940008033 canthaxanthin Drugs 0.000 description 1
- 235000009132 capsorubin Nutrition 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002113 chemopreventative effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000019247 citranaxanthin Nutrition 0.000 description 1
- PRDJTOVRIHGKNU-ZWERVMMHSA-N citranaxanthin Chemical compound CC(=O)\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-ZWERVMMHSA-N 0.000 description 1
- PRDJTOVRIHGKNU-UHFFFAOYSA-N citranaxanthine Natural products CC(=O)C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C PRDJTOVRIHGKNU-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006932 echinenone Nutrition 0.000 description 1
- YXPMCBGFLULSGQ-YHEDCBSUSA-N echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(=O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C YXPMCBGFLULSGQ-YHEDCBSUSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- GFAUNYMRSKVDJL-UHFFFAOYSA-N formyl chloride Chemical compound ClC=O GFAUNYMRSKVDJL-UHFFFAOYSA-N 0.000 description 1
- SJWWTRQNNRNTPU-ABBNZJFMSA-N fucoxanthin Chemical compound C[C@@]1(O)C[C@@H](OC(=O)C)CC(C)(C)C1=C=C\C(C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)C[C@]1(C(C[C@H](O)C2)(C)C)[C@]2(C)O1 SJWWTRQNNRNTPU-ABBNZJFMSA-N 0.000 description 1
- AQLRNQCFQNNMJA-UHFFFAOYSA-N fucoxanthin Natural products CC(=O)OC1CC(C)(C)C(=C=CC(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)CC23OC2(C)CC(O)CC3(C)C)C)CO)C(C)(O)C1 AQLRNQCFQNNMJA-UHFFFAOYSA-N 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- HRQKOYFGHJYEFS-RZWPOVEWSA-N gamma-carotene Natural products C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C=1C(C)(C)CCCC=1C)\C)/C)\C)(\C=C\C=C(/CC/C=C(\C)/C)\C)/C HRQKOYFGHJYEFS-RZWPOVEWSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000003976 gap junction Anatomy 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000004409 healthy vision Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical class CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- IFTRFNLCKUZSNG-UHFFFAOYSA-N lycoxanthin Chemical compound CC(C)=CCCC(C)=CC=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)CO IFTRFNLCKUZSNG-UHFFFAOYSA-N 0.000 description 1
- 235000008699 lycoxanthin Nutrition 0.000 description 1
- OHZZTXYKLXZFSZ-UHFFFAOYSA-I manganese(3+) 5,10,15-tris(1-methylpyridin-1-ium-4-yl)-20-(1-methylpyridin-4-ylidene)porphyrin-22-ide pentachloride Chemical compound [Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Mn+3].C1=CN(C)C=CC1=C1C(C=C2)=NC2=C(C=2C=C[N+](C)=CC=2)C([N-]2)=CC=C2C(C=2C=C[N+](C)=CC=2)=C(C=C2)N=C2C(C=2C=C[N+](C)=CC=2)=C2N=C1C=C2 OHZZTXYKLXZFSZ-UHFFFAOYSA-I 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- UGJYMKZYSUMAKJ-ZGMBEONKSA-N neurosporaxanthin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C UGJYMKZYSUMAKJ-ZGMBEONKSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000011765 phytoene Nutrition 0.000 description 1
- 230000000485 pigmenting effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 description 1
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- AIBOHNYYKWYQMM-MXBSLTGDSA-N torulene Chemical compound CC(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C AIBOHNYYKWYQMM-MXBSLTGDSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- OFNSUWBAQRCHAV-KYHIUUMWSA-N zeaxanthin monoepoxide Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C OFNSUWBAQRCHAV-KYHIUUMWSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
[0001] Novel Carotenoid Esters
[0002] This application claims the benefit of U.S. Provisional Patent Applications Nos. 60/270,817, filed February 23, 2001 and 60/347,443 filed January 11, 2002.
[0003] The carotenoids are important natural products which are involved in the photosynthetic process of plants. Carotenoids are used as nutritional supplements for animals and humans, as well as in food colorants and cosmetics. Although carotenoids are important for health, animals and humans cannot produce them, and these compounds must thus be obtained through diet from fruits and vegetables.
[0004] Several properties of the carotenoids make them important for the health of both animals and humans. For example, these compounds are antioxidants with important quenching effects on free radicals. They protect living tissues against a variety of diseases, either directly or as immunopotentiators. Additionally, carotenoids are involved in gap- junction communication among living cells. Recent epidemiological evidence has suggested an inverse relationship between the consumption of fruits and vegetables with high carotenoid content and the incidence of several types of cancers. Specifically, B-carotene, lutein and
Iycopene have been shown to exhibit a cancer-prevention effect (M.M. Mathews-Roth, Current
Chemotherapy and Infectious Diseases (J.D. Nelson and C. Grassi, Eds, Am. Soc. Microbiol,
Washington DC:1503-1505(1980)); B. P. Chew et al, Anticancer Research 16:3689-3694 (1996); P.H.Gann et al, Cancer Res. 59:1225-1230 (1999).
[0005] Additionally, several carotenoids, such as lutein and zeaxanthin, have specific functions in the retina of the eye to assure healthy vision in several animal species, including humans (J.D. Landrum ef al., Archives Biochem. Biophys. 385(1):28-40(2001)). Finally, some carotenoids have pro-vitamin A activity, whereas others control reproduction and fertility,
upregulate the Connexind3 gene, decrease the risk of degenerative disease and prevent coronary heart disease (N. Krinsky, Pure and Appl. Chem. 66(5):1003-1010 (1994).
[0006] From a chemical standpoint, carotenoids may be classified by their functional . : groups into several categories (see Key fo Carotenoids, 2nd enlarged and revised edition, H.
Pfander ef af, Birkhduser Verlag, Basel, 1987). These include hydrocarbon carotenoids such as ;
B-carotene and lycopene, monohydroxy carotenoids such as B-cryptoxanthin, dihydroxy carotenoids such as lutein and zeaxanthin, polyhydroxy carotenoids such as B,B-carotene triol, epoxycarotenoids such as violaxanthin and antheraxanthin, carbonyl carotenoids such as echinenone, capsanthin, canthaxanthin and astaxanthin, and carotenoid acids such as bixin and crocetin. :
[0007] Esters with a carotenoid as the alcohol-derived moiety are well known. For example, the monoesters and diesters of lutein and zeaxanthin with palmitic acid, myristic acid and stearic acid occur in nature. They are also known as the “xanthophylls” of the flowers and leaves of most plants (Alam, Lipids, 3:183 (1968)). These esters are also prepared commercially, as described, for example, in U.S. Patent No. 6,191,293 of Levy via the extraction of the flowers of the marigold plant (Tagetes erecta) with subsequent purification.
[0008] Additionally, some esters containing a carotenoid as the alcohol-derived moiety have been prepared synthetically. For example, the valerate, laurate, oleate, linoleate and caproate esters of the carotenoids zeaxanthin and isozeaxanthin have been described in U.S.
Patent No. 5,536,504 of Eugster, ef al. Short chain organic acid diesters of lutein and zeaxanthin have also been described in U.S. Patent No. 5,959,138 of Torres-Cardona, ef al.
[0009] Esters containing a carotenoid as the acid-derived moiety are also well known. ‘Whereas many occur in nature (“Key to Carotenoids”), other esters of this type have been prepared by synthesis. For example, U.S. Patent No. 2,768,198 of Marbet, ef al. describes the preparation of esters of bixin and norbixin with amyl alcohol, octyl alcohol and Vitamin A.
[0010] Finally, glycerides with a carotenoid acid have been prepared by enzymatic catalysis (Partali ef al, Angew. Chem Int. Ed. Engl. 35:329-330 (1996)). The reaction of B-apo-8’- carotenoic acid with Vitamin E yields a-tocopheryl-B-8’-carotenoate as described by Larsen ef al (Chem. Fur. J 4:113-117 (1998)). Additionally, the enzymatic esterification of bixin using d
L-ascorbic acid, which contains two alcoholic OH groups, as the alcohol moiety has been reported by Humean et al (Biotechnol. Lett. 22:155-168 (2000). .
[0011] In summary, although many esters containing carotenoid components are known, all of the known carotenoid esters contain a non-carotenoid component as the alcohol-derived moiety or the acid-derived moiety.
[0012] This invention is directed to esters comprising at least one alcohol-derived moiety and at least one acid-derived moiety, wherein the at least one alcohol-derived moiety comprises a hydroxy carotenoid selected from the group consisting of monohydroxy carotenoids, dihydroxy carotenoids, and polyhydroxy carotenoids, and wherein the acid-derived moiety comprises a carboxylic carotenoid selected from the group consisting of monocarboxylic carotenoids, dicarboxylic carotenoids, and polycarboxylic carotenoids. Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin, violaxanthin, carotene diol, hydroxy carotene, hydroxylycopene, alloxanthin and dehydrocryptoxanthin. Preferred carboxylic carotenoids include bixin, norbixin, B-apo-8-carotenoic acid, crocetin, diapocarotenoic acid, carboxylcarotene and azafrin.
[0013] The foregoing summary, as well as the following detailed description of preferred embodiments of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown.
[0014] In the drawings:
[0015] Fig. 1 1s a structural formula of lutein monobixinate; and
[0016] Fig. 2 is a structural formula of hitein dibixinate.
[0017] This invention is directed to a new class of esters in which both the acid-derived moiety and the alcohol-derived moiety are carotenoids. For the purposes of this disclosure, the terms “alcohol-derived moiety” and “alcohol moiety” may both be understood to refer to the fragment of the ester molecule which is derived from an alcohol. Similarly, the terms “acid-
derived moiety” and “acid moiety” both refer to the fragment of the ester molecule which is derived from a carboxylic acid.
[0018] The new class of esters, which includes monoesters, diesters and polyesters, is } . . . .. v - substantially different from known esters because both the alcohol and the acid moieties are carotenoid compounds The esters according to the present invention may thus be called : “hybrid carotenoid esters” or “all-carotenoid esters.” These all-carotenoid esters show the combined color characteristics and the combined antioxidant potential of both moieties which makes them superior to the individual carotenoid components. Their exceptionally high antioxidant potential and outstanding fat solubility make the all-carotenoid esters promising coloring agents, efficient antioxidants, pharmaceutical agents with high biological activity, and even polymeric products exhibiting unique characteristics of electrical conduction.
[0019] The all-carotenoid esters according to the present invention are prepared from the combination of at least one hydroxy carotenoid and at least one carboxylic carotenoid. Hydroxy carotenoids which may be used to form these esters may be monohydroxy carotenoids, dihydroxy carotenoids, or polyhydroxy carotenoids. While not meant to be limiting, exemplary hydroxy carotenoids are shown in Table 1. Preferred hydroxy carotenoids according to the present invention include lutein, zeaxanthin, cryptoxanthin, violaxanthin, carotene diol, hydroxycarotene, iydroxylycopene, alloxanthin and dehydrocrypioxanihin. Hydroxy carotenoids which are more preferred include lutein, zeaxanthin, cryptoxanthin and violaxanthin, and the most preferred carotenoids are hitein, zeaxanthin, and dehydrocryptoxanthin.
Table 1: Examples of hydroxy carotenoids
Alloxanthin Hydroxycarotenones
Apocarotenol Hydroxyechinenones
Astacene Hydroxylycopene
Astaxanthin Lutein
Capsanthin Lycoxanthin
Capsorubin Neurosporine
Carotenediols Phytoene
Carotenetriols Phytofluoene
Carotenols Rodopin
Citranaxanthin Spheroidine ,
Cryptoxanthin Torulene oo
Decaprenoxanthin Violaxanthin
Denethylated-spheroidine Zeaxanthin -.
Epilutein
Fucoxanthin
[0020] The carboxylic carotenoid according to the present invention may be a monocarboxylic carotenoid, dicarboxylic carotenoid or polycarboxylic carotenoid. While not : meant to be limiting, exemplary carboxylic carotenoids are shown in Table 2. Preferred carboxylic carotenoids include bixin, norbixin, B-apo-8’-carotenoic acid, crocetin, diapocarotenoic acid, carboxylcarotene, and azafrin. More preferred carboxylic carotenoids mclude bixin, norbixin, crocetin and B-apo-8’-carotenoic acid, whereas bixin, norbixin, and B- apo-8’-carotenoic acid are the most preferred carboxylic carotenoids.
Table 2: Examples of carboxylic carotenoids
Apocarotenoic acid Crocetin
B-apo-8’-carotenoic acid Diapocarotenoic acid
Azafnn Neurosporaxanthin
Bixin Norbixin
Carboxylcarotenes Lycopenoic acid {0021} Depending on the particular carotenoid components and the stoichiometric proportion of the reactant carotenoids used for the esterification reaction, the resulting carotenoid ester may be a dicarotenoid monoester, a tricarotenoid diester or a polycarotenoid polyester. For example, dicarotenoid monoesters originate from the reaction of one molecule of a dihydroxy carotenoid, such as lutein or zeaxanthin, with one molecule of a monocarboxylic carotenoid, such as bixin. Tricarotenoid diesters are the result of the reaction of one molecule of a dihydroxy carotenoid with two molecules of a monocarboxylic carotenoid. Finally, polycarotenoid polyesters result from the reaction of several molecules of a dihydroxy carotenoid with several molecules of a dicarboxylic carotenoid, such as norbixin. Examplary possible combinations of carotenoid esters of lutein with bixin, norbixin and apocarotenoic acid are shown in Table 3.
Table 3: Types of all-carotenoid esters
Alcohol Moiety Acid Moiety Ester
Lutein (one mol) Bixin (one mol) Lutein monobixinate
Lutein (one moi) Bixin (one moi) Dehydrocryptoxanthin
Monobixinate
Lutein (one mol) Bixin (two mol) Lutein dibixinate
Lutein (one mol) Norbixin (one mol) Lutein norbixinate
Lutein (one mol) Norbixin (two mols) Lutein dinorbixinate
Lutem (two mols) Norbixin (one mol) Dilutein norbixinate : Lutein (molar excess) Norbixin (excess) Polylutein polynorbixinate
Lute (one mol) Apocarotenoic Acid Lutein monoapocarotenoate , } (one mol) J
Lutein (one mol) Apocarotenoid Acid Lutein di-apocarotenoate (two mols) ’
[0022] The structural formulas of two esters formed from the reaction of lutein and bixin,
Iutein monobixinate and lutein dibixinate, are shown in Figures 1 and 2, respectively.
Interestingly, the second ester product shown in Table 3 is the bixinate of anhydrolutein or 3°,4"-dehydrocryptoxanthin, which was obtained as an unexpected byproduct of the reaction between lutein and bixin. This compound was formed by a dehydration reaction of the unreacted hydroxyl group of lutein.
[0023] The esterification of the dicarboxylic carotenoid norbixin with the dihydroxy carotenoid lutein proceeds on both sides of both reactant molecules to form a polymeric ester, comparable to the well-known polyester material obtained by esterification of ethylene glycol with terephthalic acid, which is spun into a fiber called Dacron™ The polycarotenoid polyesters of the present invention not only have unique antioxidant and light absorbing properties, but because of their highly unsaturated polymeric nature, they are plastics with unique characteristics of electrical conduction. They may be used as “molecular wires” for electrical transmission and as semiconducting polymers in novel applications for fuel cells, plastic circuitry, light-emitting devices and transistors, for example.
[0024] The esters in which both the acid moiety and the alcohol moiety are carotenoids may be prepared by any method known in the art for esterification, including those known in the general chemistry laboratory and in the industrial setting for esterifying alcohols with acids.
The first method comprises reacting at least one hydroxy carotenoid directly with at least one carboxylic carotenoid. For example, the esterification of a hydroxy carotenoid with a carboxylic carotenoid is possible by known catalytic techniques, as for example through carbodiimide coupling in the presence of dimethylaminopyridine. Enzymatic esterification with a lipase is yet another way of preparing these carotenoid esters. ¢
[0025] In a preferred embodiment, an acid chloride of at least one carboxylic carotenoid is used as the intermediate for the esterification. The acid chloride may be prepared by any Nn method known in the art such as via the known reactions with phosphorus tri- or pentachloride,
with thionyl chloride, or with the highly-reacting formyl chloride (McGill U., Tetrahedron
Letters (1997) 38(37):6489). In a more preferred embodiment, the acid chloride is prepared from the-reaction of the carboxylic carotenoid with oxalyl chloride. This acid chloride is then reacted with at least one hydroxy carotenoid to form the desired carotenoid ester.
[0026] The invention will best be described in more detail with respect to the following non-limiting examples.
EXAMPLE 1
[0027] Lutein monobixinate, as shown in Figure 1, was synthesized according to the following procedure. Bixin (500 mg, 1.27 mmol) was converted to bixinoyl chloride in dry dichloromethane (50 mL) by the addition of oxalyl chloride (500 pL, 5.25 mmol) and N;N- dimethylformamide (1 drop). The mixture was stirred at room temperature for 1 hour and then was evaporated to dryness under reduced pressure to yield bixinoyl chlonde.
[0028] Bixinoyl chloride (4 mg, 25 umol) was mixed with lutein (1 mg, 1.76 pmol) in 1 mL of dry toluene. Pyridine (1 drop) was added and the mixture was stirred at room temperature for 6 days. The esterification reaction was monitored by thin-layer chromatography (TLC) on a silica plate with 20% ethyl acetate in dichloromethane as the developing phase. The reaction was considered complete when the spot of the reactant lutein (Rf =0.2) had largely disappeared and a new, less polar, red spot had appeared which ran almost at the solvent front (Rf - 0.95).
[0029] At this stage, the mixing was stopped and the reaction mixture was evaporated under reduced pressure. The dry residue was dissolved in diethyl ether (2 mL) and chromatographed on a silica column with diethyl ether as the eluent. The front running material was collected and evaporated under reduced pressure to give lutein monobixinate, which was purified by column chromatography on silica.
[0030] Analysis of the product by TLC on silica with 20% ethyl acetate in dichloromethane gave a single spot of Rf=0.95. "H Nuclear Magnetic Resonance (NMR) analysis on a Brucker
AC2S0 at 250 MHz in CDCl; showed the methyl ester resonance of bixin at 3.75 ppm and the double bond doublets of bixin at 7.4 ppm and 7.95 ppm. The lutein signals were observed at 3.9 ppm and 4.19 ppm, as well as the aliphatic proton resonances at 0.7-1.9 ppm. The upfield movement of the lutein signal from 3.9 ppm to 3.15 ppm is indicative of the change from the free iydroxyl to the coupled ester. The purified product thus contained the ester formed from the combination of bixin and lutein. The mass spectrum obtained using the APCI technique
(Atmospheric Pressure Chemical lonization) showed a peak at 944 consistent with lutein monobixinate (CgsHgqOs). : EXAMPLE 2
[0031] Lutein dibixinate, as shown in Figure 2, was prepared according to the following . process. Bixin (550 mg, 1.39 mmol) was converted to bixinoyl chloride in dry toluene (10 mL) by the addition of oxalyl chloride (1 mL, 10.5 mmol) and refluxed under nitrogen for 1 hour to give a blood-red solution. The mixture was allowed to cool slightly and then evaporated to dryness under reduced pressure to yield bixinoy! chloride.
[0032] Bixinoyl chloride (8 mg, 19.4 pmol) was mixed with lutein (1 mg, 1.76 pmol) in 1 mL of dry toluene. A mixture of pyridine and 4-N,N-dimethylamino pyridine (2 drops) was added and the mixture refluxed for § hours. The esterification reaction was monitored using
TLC on assilica plate with 20% ethyl acetate in dichloromethane as the developing phase.
During the reaction, the spot of the reactant lutein (Rf=0.2) had largely disappeared and two new, less polar, red spots had appeared which ran almost at the solvent front (lutein monobixinate Rf=0.95 and lutein dibixinate Rf=0.98). As the reaction went to completion, only the spot with Rf =0.98 remained. At this stage the mixture was evaporated under reduced pressure. The dry residue was dissolved in diethyl ether (2 mL) and chromatographed on a silica column with elution by diethyl ether. The front running material was collected and evaporated under reduced pressure to give lutein monobixinate.
[0033] Analysis of the ester by TLC on silica developed with 20% ethyl acetate in dichloromethane gave a single spot of Rf=0.99; "TH NMR analysis (Brucker 250 MHz, CDCl) showed resonances at 3.7 ppm (double intensity bixin methyl ester resonance) and 0.6-1.6 ppm (lutein resonances). The mass spectrum determined by APCI showed a peak with mass 1323 consistent with lutein dibixinate (CooHj1203).
EXAMPLE 3
[0034] Lutein mono-B-apo-8’-carotenoate was prepared as follows. The acid chloride of
B-apo-8’-carotenoic acid was prepared in the same way as was the bixinoyl chloride of .
Example 2. The acid chlorzde (1.03 g, 2.5 mmol) was dissvlved 1 benzene (10 mL). To tlus was added a solution of lutein (3.7 g, 6.55 mmol) and pyridine (1.2 mL, 12.8 mmol) in benzene a (10 mL) under argon. The reaction was stirred at room ternperature for 3 days.
[0035] The reaction mixture was diluted with ether (80 mL), washed with dilute hydro- chlonic acid (0.5M, 2x50 mL), dried (Na,SO,) and evaporated. Dry flash chromatography (loading with dichloromethane and eluting with 20%, 40% and 60% ethyl acetate in light . petroleum) yielded a product which, by mass spectrometry, showed a peak at mass 808 consistent with the ester lutein mono-f3-apo-8’-carotenoate (CssHggOs).
[0036] All of the new all-carotenoid esters may be useful coloring agents for fats due to their high oil solubility. Additionally, the molecular combination of these carotenoids may also increase the chemopreventive anti-cancer activity of the individual carotenoid components and protect against a variety of pathological conditions. Finally, they may be useful antioxidants due to the combination and synergistic potentiation of the antioxidant action of their carotenoid components. For example, lutein dibixinate contains 29 carbon-carbon double bonds and 4 carbon-oxygen double bonds, 31 of which are of the conjugated type. This all-carotenoid diester is one of the most highly unsaturated compounds known, exhibiting unprecedented light absorbing and antioxidant properties.
[0037] The mono-, di- and poly- all carotenoid esters according to the present invention are thus novel compounds because they contain at least two carotenoid moieties. By combining at least two carotenoids into a single compound via a synthetic ester linkage, the similar and complementary properties of the individual carotenoids are maximized. These all-carotenoid esters exhibit significantly greater antioxidant and physiological effects than the sum of the individual activities of the component carotenoids. As a result, the new all-carotenoid esters may be useful as therapeutic agents, pigmenting ingredients in poultry feed and as coloring agents for fats. Additionally, all-carotenoid polyesters may act as molecular wires exhibiting unique electrical conductance characteristics.
[0038] It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.
Claims (3)
- . We claim:: 1. An ester comprising at least one alcohol-derived moiety and at Jeast one acid- derived moiety, wherein the at least one alcohol-derived moiety comprises a hydroxy carotenoid selected from the group consisting of monohydroxy carotenoids, dihydroxy carotenoids, and polyhydroxy carotenoids, and wherein the at least one acid-derived moiety comprises a carboxylic carotenoid selected from the group consisting of monocarboxylic carotenoids, dicarboxylic carotenoids, and polycarboxylic carotenoids.
- 2. The ester according to claim 1, wherein the hydroxy carotenoid is selected from the group consisting of lutein, zeaxanthin, cryptoxanthin, viclaxanthin, carotene diol, hydroxycarotene, hydroxylycopene, alloxanthin and dehydrocryptoxanthin.
- 3. The ester according to claim 1, wherein the carboxylic carotencid is selected from the group consisting of bixin, norbixin, -apo-8’-carotenoid acid, crocetin, diapocarotenoic acid, carboxylcarotene, and azafrin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27081701P | 2001-02-23 | 2001-02-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200305725B true ZA200305725B (en) | 2004-07-26 |
Family
ID=34078834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200305725A ZA200305725B (en) | 2001-02-23 | 2003-07-24 | Novel carotenoid esters. |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA200305725B (en) |
-
2003
- 2003-07-24 ZA ZA200305725A patent/ZA200305725B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2438876C (en) | Novel carotenoid esters | |
AU2002258077A1 (en) | Novel carotenoid esters | |
US6743953B2 (en) | Process for the preparation of xanthophyll crystals | |
US5876782A (en) | Method for the conversion of xanthophylls in plant material | |
US5849345A (en) | Carotenoid ketones and esters | |
DE2535963C3 (en) | Chicken feed | |
Grung et al. | Algal carotenoids 52; secondary carotenoids of algae 3; carotenoids in a natural bloom of Euglena sanguinea | |
EP1487930A2 (en) | Esterification of xanthophylls | |
ZA200305725B (en) | Novel carotenoid esters. | |
US3558712A (en) | Method for the synthesis of zeaxanthins,xanthophylis,and 3-oxo-beta carotene | |
KR20170005886A (en) | Method for preparing astaxanthin monoesters | |
US5386063A (en) | Synthesis of (all-E)-2,7,-dimethylocta-2,4,6-triene-1,8-dial13 C4 | |
US3468931A (en) | 4'-substituted derivatives of 1,18-di(2',3',6'-trimethylphenyl-(1'))-3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene | |
González-Araúz et al. | Antioxidant capacity assessment by abts of 9'Z-bixin, 9'Z-norbixin, 9'Z-methylbixin and all e-methylbixin from bixa orellana seeds | |
Nagy et al. | Chemical Synthesis of Carotenoid Esters | |
US3403184A (en) | Carotenoid compounds | |
CN114044749A (en) | Preparation method and application of dihydroxy zeaxanthin diacetate | |
Háda | SYNTHESIS OF WATER-SOLUBLE CAROTENOIDS AND CAROTENOID DENDRIMERS | |
Julliard | Development and optimization of a new pathway for the synthesis of lutein and other unsymmetrical carotenoids, utilizing a modified Julia coupling methodology |